Aptar Digital Health

What Aptar Digital Health does

Aptar Digital Health is a division of Aptar Group (NYSE: ATR) that builds end-to-end digital health solutions for global pharmaceutical and biotech companies, operating from Louveciennes, France and Crystal Lake, USA with reach across 120 countries. The portfolio spans patient-facing mobile applications (Migraine Buddy, Esme for multiple sclerosis, Allergy Buddy), FDA-regulated Software as a Medical Device products (Oleena prescription oncology app; HeroTracker Sense respiratory monitor, 510(k)-cleared October 2025), connected drug delivery devices (AdhereIT auto-injector add-on, iPUMP), and end-to-end Disease Management Platforms. The underlying platform is cloud-native (Microsoft Azure and AWS, with data residency in France for EEA compliance), ISO 13485/27001/MDSAP certified, HIPAA and GDPR compliant, and includes a Digital Diagnostics (DDx) AI/ML module and Study & Data Services for virtual clinical trials and real-world evidence generation.

The company operates a B2B enterprise model, selling custom annual subscription and licensing agreements to pharmaceutical partners who embed companion apps, SaMD, and connected devices alongside specific drug products from clinical trials through commercialization. Customer relationships span top-tier global pharma including AbbVie, BMS, Novartis, Sanofi, Merck, Biogen, AstraZeneca, Chiesi, Stallergenes Greer, and Biohaven, as well as healthcare providers (Moffitt Cancer Center) and academic partners (University of Geneva). Growth is driven by strategic acquisitions (notably Healint in February 2024, which brought Migraine Buddy and a Singapore base) and a series of device, wearable, and AI partnerships (Enable Injections, SHL Medical, Oura, Legit.Health, Iona Mind) that deepen the ecosystem around regulated drug delivery and patient engagement.

Name

Aptar Digital Health

Legal name

Aptar Europe Holding SAS

Website

https://aptardigitalhealth.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

101–250 employees

Short description

Aptar Digital Health, a division of Aptar Group, builds companion apps, FDA-cleared SaMD, and connected drug delivery devices for global pharmaceutical partners, serving neurology, oncology, respiratory, and immunology patient journeys from clinical trials through commercialization.

Ownership category

akta.pro rank

Product category

Digital Health Platforms

NAICS

Software Publishers (513210), Software Publishers (5132)

SIC

Services-Prepackaged Software (7372), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Therapeutic Companion Apps (Drug-Device-Digital Combination) (HLACANAH)

akta.pro secondary industries

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL), DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), DTx/SaMD Evidence, Outcomes & Real-World Data (RWE) Platforms (HLACANAM)

Keywords

• Digital health platforms
• Connected drug delivery
• Software as a medical device
• Patient support apps
• Digital therapeutics

Headquarters

HQ city

Congers

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Supply Chain, Operations, Infrastructure, Marketing or Sales

Revenue model

1. Software as a Medical Device (SaMD): Regulated software solutions designed to address specific pain points in the patient journey, from disease identification to treatment management. These are medical devices subject to regulatory oversight and require clinical evidence for validation.
2. Companion Apps / Digital Patient Support Programs: Non-regulated digital tools designed to improve patient onboarding and adherence to specific treatments. Typically provided as stand-alone solutions or embedded modules within existing digital health products.
3. Connected Drug Delivery Devices: Hardware/software combinations including AdhereIT connected auto-injector and other integrated drug delivery systems that support self-administration and capture usage data.
4. Disease Management Platforms: Comprehensive end-to-end platforms supporting patients throughout their treatment journey with multi-component solutions including administration devices, wearables, and sensors.
5. Study & Data Services: Virtual clinical trial support, patient recruitment through user communities, real-world evidence generation, and clinical study services for pharmaceutical companies.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Aptar Digital Health develops cloud-native digital health solutions including software as a medical device (SaMD), companion and patient support applications, a Disease Management Platform, digital diagnostics, and connected drug delivery devices (AdhereIT, HeroTracker Sense, iPUMP). The offering is sold primarily to pharmaceutical, biotech, and MedTech manufacturers to support adherence, clinical trials, and patient engagement across the treatment lifecycle.

Product overview

Aptar Digital Health provides an ecosystem of digital health solutions combining hardware and software across regulated and non-regulated products. The core portfolio includes patient-facing mobile applications (Migraine Buddy, Esme, Allergy Buddy), FDA-cleared Software as a Medical Device (Oleena oncology app, HeroTracker Sense respiratory monitor), connected drug delivery devices (AdhereIT auto-injector, iPUMP), and Disease Management Platforms. These are supported by Software as a Medical Device modules, Digital Patient Support Programs, and Digital Diagnostics (DDx) AI capabilities. The platform integrates with connected devices, EHR systems, and offers Study & Data Services for virtual clinical trials. Services span patient identification, patient communities, patient activation, and comprehensive implementation, hosting, and regulatory support.

Differentiator

Problem solved

Functional benefit

Brands

• Migraine Buddy: A mobile app that helps people with migraine and headache disorders track symptoms, triggers, and treatments.
• Esme
• Allergy Buddy
• Oleena
• AdhereIT
• HeroTracker Sense
• iPUMP

Products and services

• Migraine Buddy

Quantifiable outcome

• Less than 50% of patients continue adhering to treatment after six months without digital support, with digital companion solutions significantly improving adherence rates
• +3 more outcomes

Named customers11 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability6 records

Feature9 records

Partnerships

Eleven partnerships are on record, tiered core and secondary.

• AWS (Amazon Web Services)coreOthers · 9 April 2026Primary cloud infrastructure provider for hosting digital health solutions. HDS certified, GDPR-compliant with Standard Contractual Clauses for international data transfers. Data storage region set to France for EEA compliance.
• Microsoft AzurecoreOthers · 9 April 2026Data analytics platform infrastructure using Azure Data Factory and PowerBI. HDS certified cloud hosting with Data Processing Agreement ensuring GDPR compliance. Azure region selected in France for data residency compliance.
• Enable InjectionscoreStrategic or Co-development Partner · 8 April 2026Strategic partnership making Aptar Digital Health the preferred digital health partner for Enable's enFuse On-Body Delivery System. Develops companion digital solution supporting patients throughout injection process including treatment data recording, onboarding modules, injection guidance, and patient-reported outcomes tracking. Solution designed to support pharmaceutical partners from clinical trials through commercialization.
• ŌURAcoreTechnology or Integration · 6 January 2026Partnership to integrate biometric data from ŌURA Ring into Migraine Buddy app. Combines subjective symptom logs with objective health signals including sleep, HRV, and temperature to help users identify migraine triggers. Emphasizes women's health by leveraging ŌURA's cycle tracking insights for hormonal factors in migraine management.
• University of GenevasecondaryStrategic or Co-development Partner · 21 November 2024Collaboration with Quality of Life (QoL) technologies lab to advance migraine scientific research. Migraine-related data collected through Migraine Buddy app to deepen understanding of migraine and improve lives of those living with the condition.
• SHL MedicalcoreStrategic or Co-development Partner · 1 June 2024Strategic partnership to develop connected drug delivery solutions combining digital health expertise with advanced self-injection technologies. Integrates digital capabilities with SHL's auto-injector platforms to improve self-injection therapy outcomes.
• Iona MindsecondaryStrategic or Co-development Partner · 29 May 2024Partnership to deliver scalable mental health support to chronic disease patients. Combines Iona Mind's low-intensity CBT solutions with Aptar Digital Health's platform to address psychological stress and emotional wellbeing.
• HealintcoreOEM/ Whitelabel/ Licensing Partner · 21 February 2024Acquisition of Singapore-based digital health company Healint to enhance neurological portfolio and global presence. Healint's migraine tracking technology (Migraine Buddy) strengthens Aptar's digital health offerings in CNS conditions and clinical trial capabilities.
• Moffitt Cancer CentercoreStrategic or Co-development Partner · 18 January 2024Clinical evaluation partnership for Oleena digital therapeutic in head and neck cancer. 15-month study assessing usability, patient satisfaction, engagement, symptom burden, anti-cancer treatment adherence, and quality of life outcomes.
• Legit.HealthsecondaryTechnology or Integration · 1 December 2023Partnership to integrate advanced dermatology diagnostic technology into Aptar Digital Health platform for immuno-dermatology patient care. Combines AI-powered visual assessment tools with digital health platform capabilities.
• Noble (Aptar Pharma company)coreOthers · 1 September 2022Internal partnership with Noble, an Aptar Pharma company specializing in patient onboarding and training for self-administered therapies. Collaborates on optimizing design and development of digital solutions for patient self-administration support.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Omada Health: Digital chronic care platform combining connected devices, coaching and software for diabetes, hypertension and behavioral health. Comparable as a full-stack disease management platform competing for payer and pharma digital health budgets.
• Voluntis (AstraZeneca): Now part of AstraZeneca's oncology digital health unit after acquisition; historically a direct peer in SaMD companion apps and connected drug delivery monitoring, with overlapping therapeutic focus and pharma partnership model.
• Propeller Health (ResMed): Connected respiratory inhaler platform and patient companion app, acquired by ResMed. Directly comparable to Aptar Digital Health's HeroTracker Sense respiratory solution and Allergy Buddy in connected respiratory care.
• Welldoc: Multi-condition digital health platform offering FDA-cleared SaMD for diabetes, hypertension and heart failure. Directly comparable to Aptar Digital Health's Disease Management Platform and SaMD modules, with similar pharma partnership GTM.
• Click Therapeutics: Prescription digital therapeutics company developing regulated software for chronic conditions, partnered with pharma (e.g., Pfizer, Boehringer Ingelheim). Directly comparable to Aptar Digital Health's SaMD and companion app strategy targeting pharma.
• mySugr (Roche): Diabetes companion app with millions of users, integrated into Roche's diabetes franchise. Comparable as a consumer-grade chronic disease companion app operating inside a major pharma parent's portfolio.
• Biofourmis: AI-driven remote monitoring and digital therapeutics platform with pharma and hospital customers. Comparable in combining connected biosensors, AI analytics and SaMD-style software to support therapy management, overlapping with Aptar Digital Health's DDx and RPM stack.
• Kaia Health: Digital therapeutics company offering app-based therapies for musculoskeletal pain and COPD, with enterprise and payer distribution. Comparable as a regulated digital therapeutic peer serving chronic disease populations via B2B2C channels.
• Akili Interactive: Prescription digital therapeutic company with FDA-cleared SaMD products targeting neurological conditions. Comparable as a regulated, prescription-grade digital therapeutic peer competing for similar pharma and provider partnerships.
• Better Therapeutics: Prescription digital therapeutics company developing cognitive behavioral therapy apps for cardiometabolic conditions, with FDA submission pathway. Comparable as a regulated SaMD peer competing for the same chronic-disease pharma partnerships.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/aptardigitalhealth

Compliance15 records

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aptar Digital Health